Jermain Patrick John

CFO Jermain Patrick John sells 3,587 shares of PLXS at $204.09; holds 16,882 shares post-transaction.

Jermain Patrick John, serving as Executive Vice President & CFO, sold 3,587 shares on 2026-02-04 at $204.09 for a total value of $732,070.83, reducing his holdings from 20,469 shares to 16,882 shares, a reduction of 17.5%. The sale occurred near the stock's 52-week high of $206.22, after the stock appreciated 33.0% over the prior 30 days and 44.0% over the prior 90 days. Looking at his prior trades at PLXS, 4 of 5 measurable same-ticker sales show mixed outcomes—two were followed by 90-day gains (+2.6% and +11.8%, +12.4%, +6.5%), while one showed a small 90-day loss (-1.6%)—with none classified as well-timed. His cross-ticker track record shows 8 prior sells with an average 90-day return of +13.5% and a 0.00% well-timed rate, indicating his sales historically have been poorly timed (stock typically rose afterward). The current P/E of 32.27 and recent annual revenue decline of -1.1% provide context for the company's valuation, though the sale size relative to his remaining position of 16,882 shares and the timing near the 52-week high merit monitoring.

CFO Jermain Patrick John sold 4,841 shares of PLXS at $204.01; stock up 33.9% in 30d, 40.1% in 90d.

Jermain Patrick John (Exec. VP & CFO) sold 4,841 shares (19.1% reduction) at $204.01 on 2026-02-03 as the stock trades near its 52-week high of $204.96. The timing occurs during a pronounced rally: 30-day return +33.9% and 90-day return +40.1%. At PLXS specifically, John's prior 5 sales generated mixed timing outcomes—none were well-timed (0 of 5 had negative 90-day returns). His cross-ticker track record of 7 prior sells shows an average 90-day return of +13.5% with a 0.00% well-timed rate, indicating that his sales have historically not preceded price declines. Fundamentally, PLXS trades at a P/E of 24.38 with annual revenue declining 1.1% year-over-year, though the company posted net income of $45.1M most recently. The sale itself reduces his holdings to 20.5K shares but does not establish a new directional signal given his historical sale patterns at this ticker.

CFO Jermain Patrick John sold 4,328 PLXS shares at $132.29; stock down 22.0% from 52-week high, 5 prior same-ticker sales show no well-timed pattern (0 of 5 profitable at 90-day mark).

Jermain Patrick John, Exec. VP & CFO, sold 4,328 shares for $572,554.15, reducing holdings from 29,965 to 25,637 shares. The stock has declined 22.0% from its 52-week high of $170.49 and is -4.4% over the past 90 days, but has rebounded +8.4% in the past 30 days. His prior trading record at PLXS shows 5 previous sells, none of which were well-timed at the 90-day mark—all 5 subsequent 90-day periods showed positive returns, meaning the insider sold before rallies rather than before declines. Fundamentally, the company faces revenue headwinds (-5.6% annual growth) with latest quarterly revenue of $980,170.00 and net income of $39,073,000.00; the valuation stands at a P/E of 25.23.

CFO Jermain Patrick John sold 5,045 shares of PLXS at $143.13 on 2024-10-28 for $722.1K; stock now at $146.58.

Jermain Patrick John sold 5,045 shares representing a 17.0% reduction in his PLXS holdings, executed at $143.13, while the stock has since risen to $146.58 in a +0.0% move from its 52-week high. His prior trades at PLXS show a 0 of 5 well-timed sells at the 90-day mark, with the immediate prior two sales on 2024-07-29 followed by +1.3% and +0.8% 30-day returns, continuing a pattern where the stock generally moved higher after his dispositions. The sell occurred in an elevated valuation context (P/E of 36.01) following strong 90-day momentum (+17.7%) and occurs against a pattern at this ticker where insider sales have not preceded material declines.

CFO Jermain Patrick John sold 4,536 shares at $125.79 avg for $570.6K; holds 29.6K shares post-sale.

CFO Jermain Patrick John executed 2 separate sales on 2024-07-29, offloading 4,536 shares at an average of $125.79 for $570.6K, reducing his holding by 13.3% from 34.2K shares to 29.6K shares. At the current price of $128.17, the stock is -1.3% from its 52-week high of $129.85 and has risen 24.7% over the past 30 days and 24.0% over the past 90 days. His prior 2 measurable same-ticker sells (2024-05-02 and 2024-05-01) both posted positive 90-day returns of +23.2% and +24.6% respectively, indicating the stock continued to advance after those exits, not a pattern of well-timed pre-decline selling at this ticker. The company shows solid fundamentals with $997.5M quarterly revenue, +10.0% annual growth, though the P/E of 34.55 reflects elevated valuation.